1. Home
  2. CAI vs CELH Comparison

CAI vs CELH Comparison

Compare CAI & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAI
  • CELH
  • Stock Information
  • Founded
  • CAI 2008
  • CELH 2004
  • Country
  • CAI United States
  • CELH United States
  • Employees
  • CAI N/A
  • CELH N/A
  • Industry
  • CAI Medical Specialities
  • CELH Beverages (Production/Distribution)
  • Sector
  • CAI Health Care
  • CELH Consumer Staples
  • Exchange
  • CAI Nasdaq
  • CELH Nasdaq
  • Market Cap
  • CAI 10.1B
  • CELH 12.0B
  • IPO Year
  • CAI 2025
  • CELH N/A
  • Fundamental
  • Price
  • CAI $36.80
  • CELH $61.10
  • Analyst Decision
  • CAI Strong Buy
  • CELH Strong Buy
  • Analyst Count
  • CAI 6
  • CELH 18
  • Target Price
  • CAI $35.50
  • CELH $60.11
  • AVG Volume (30 Days)
  • CAI 705.9K
  • CELH 8.0M
  • Earning Date
  • CAI 08-12-2025
  • CELH 08-07-2025
  • Dividend Yield
  • CAI N/A
  • CELH N/A
  • EPS Growth
  • CAI N/A
  • CELH N/A
  • EPS
  • CAI N/A
  • CELH 0.39
  • Revenue
  • CAI $533,847,000.00
  • CELH $1,666,480,000.00
  • Revenue This Year
  • CAI $59.70
  • CELH $77.70
  • Revenue Next Year
  • CAI $50.34
  • CELH $25.16
  • P/E Ratio
  • CAI N/A
  • CELH $154.63
  • Revenue Growth
  • CAI 106.53
  • CELH 11.85
  • 52 Week Low
  • CAI $25.40
  • CELH $21.10
  • 52 Week High
  • CAI $42.50
  • CELH $63.50
  • Technical
  • Relative Strength Index (RSI)
  • CAI N/A
  • CELH 67.54
  • Support Level
  • CAI N/A
  • CELH $59.63
  • Resistance Level
  • CAI N/A
  • CELH $63.50
  • Average True Range (ATR)
  • CAI 0.00
  • CELH 1.90
  • MACD
  • CAI 0.00
  • CELH -0.15
  • Stochastic Oscillator
  • CAI 0.00
  • CELH 70.55

About CAI Caris Life Sciences Inc. Common Stock

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

About CELH Celsius Holdings Inc.

Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), Celsius On-the-Go powder packets, and the recently acquired portfolio of Alani Nu energy drinks and snacks. Celsius dedicates its efforts to branding and innovation, while it largely utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.

Share on Social Networks: